- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
8
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
8 companies
TTY Biopharm
Market Cap: NT$19.2b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$76.10
7D
-0.5%
1Y
-0.4%
Cenra
Market Cap: NT$5.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$34.85
7D
-0.3%
1Y
1.3%
Maxigen Biotech
Market Cap: NT$3.6b
Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$40.05
7D
-0.9%
1Y
-6.6%
Allied Biotech
Market Cap: NT$2.3b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$23.45
7D
3.1%
1Y
35.2%
TSH Biopharm
Market Cap: NT$2.0b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.70
7D
-0.2%
1Y
8.3%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$29.70
7D
-0.5%
1Y
-6.1%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$798.3m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$8.55
7D
-4.3%
1Y
-24.3%
Bioray Biotech
Market Cap: NT$505.9m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$16.65
7D
-2.6%
1Y
-39.6%